Autopsy report · NCT00587015
A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Patients With Non-Hodgkin's Lymphoma (NHL)
Cause of deathDrug or device supply
“Due to a lack of IP supply and then terminated because they were combined into one new study with the new IP formulation.”
Life of this trial
- Registered 4 months after it had already started.
- Ran for about 2 years 2 months before it stopped.
- 50 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- MedImmune LLC
- Sponsor type
- Industry
- Conditions
- Lymphoma
- Interventions
- CAT-8015
- Participants
- 50 (planned, not actual)
- Sites
- 3
- Countries
- Poland, United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.